Skip to content

Glaucoma Eye Drop Instillation: Impact of Education

Glaucoma Eye Drop Instillation: Impact of Education

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01416415
Enrollment
119
Registered
2011-08-15
Start date
2011-08-31
Completion date
2013-06-30
Last updated
2018-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Open-Angle

Keywords

Glaucoma, Open-Angle, Ophthalmic Solutions, Eye drops, Instructional Films and Videos

Brief summary

The purpose of this study is to assess whether an educational intervention will have a positive effect on patients' ability to properly administer eye drops. The investigators predict that the educational intervention will have a positive impact on the efficacy, safety, and efficiency with which patients administer their eye drops.

Detailed description

Glaucoma is a leading cause of irreversible vision loss worldwide, and as such has a large public health impact. The only treatment proven to slow or arrest the progression of the disease process is intraocular pressure (IOP) reduction, which relies heavily on patient cooperation. Previously, nonadherence to glaucoma medications has ranged from 24% to 59%. Barriers to medication compliance in the glaucoma patient population include health literacy, poor comprehension of disease, poor comprehension of medication regimen, and improper eye drop administration technique. The purpose of this randomized, controlled clinical trial is to assess whether an educational intervention will have a positive effect on patients' ability to properly administer eye drops. Patients randomized to the experimental group will receive the educational intervention, consisting of an instructional video demonstrating how to instill eyedrops. Patients randomized to the control group will receive an attention placebo, consisting of a video regarding healthy eating tips. Additional measures that will be obtained from all patients include a health literacy score, as measured using the REALM questionnaire, and a BMQ - specific score (Beliefs about Medicines Questionnaire) using the BMQ-specific questionnaire. If the education protocol is found to positively affect eye drop administration success, as demonstrated by a statistically significant difference between the experimental and control groups, suggestions will be proposed for the implementation of educational programs similar to ours to improve glaucoma patient outcomes.

Interventions

OTHERVideo education on proper eye drop instillation technique

The video is approximately seven minutes long and teaches the Robert Ritch method of instilling eye drops.

OTHERPlacebo video education on healthy eating tips

The video is approximately seven minutes long and teaches tips to promote healthy eating.

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Established care with the treating ophthalmologist for at least 6 months * Diagnosis of open-angle glaucoma or ocular hypertension * The use of one, two or three self-instilled eye drop medications in one or two eyes * Age 40-85 years * Fluency in English * Best corrected visual acuity (BCVA) of 20/50 or better in each eye

Exclusion criteria

* Presence of moderate to severe cognitive deficits * Presence of a clinically significant tremor * Mini Mental Status Exam score ≤ 20

Design outcomes

Primary

MeasureTime frameDescription
Eye drop instillation score4 +/- 3 monthsThe eye drop instillation score is a composite score of the efficacy, safety, and efficiency with which the subject instills their eyedrops and is simply a measure of how well the subject administers their eyedrops.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026